Added to YB: 2024-12-13
Pitch date: 2024-12-12
PRTC [bullish]
PureTech Health plc
-18.58%
current return
Author Info
The Oak Bloke shares analysis of the UK stock market, particularly overlooked small caps. Sign up for the newsletter.
Company Info
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
Market Cap
GBP 374.8M
Pitch Price
GBP 20.77
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.62
P/E
7.70
EV/Sales
31.32
Sector
Biotechnology
Category
value
PRTC-ical ideas shine in 2025
PRTC: Undervalued biotech with 80% clinical success rate. $14bn Karuna sale, $292.6m cash. LYT-100 Phase 2B results due Q4'24. $500m potential royalties from Karuna's Cobenfy. 4 wholly-owned pipeline products. Low case NAV £1.23/share, high case £5.17/share. 69% discount to future NAV. £394m cash provides optionality.
Read full article (9 min)